ONCOARRESTIN Trademark

Trademark Overview

On Monday, July 29, 2002, a trademark application was filed for ONCOARRESTIN with the United States Patent and Trademark Office. The USPTO has given the ONCOARRESTIN trademark a serial number of 76435991. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 28, 2012. This trademark is owned by OncoArrestin, LLC. The ONCOARRESTIN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

product research and development, namely, molecular analysis; technical consultation in the field of molecular development
oncoarrestin

General Information

Serial Number76435991
Word MarkONCOARRESTIN
Filing DateMonday, July 29, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 28, 2012
Registration Number3060616
Registration DateTuesday, February 21, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 25, 2003

Trademark Statements

Goods and Servicesproduct research and development, namely, molecular analysis; technical consultation in the field of molecular development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 28, 2012
Primary Code042
First Use Anywhere DateSaturday, November 19, 2005
First Use In Commerce DateSaturday, November 19, 2005

Trademark Owner History

Party NameOncoArrestin, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressGaithersburg, MD 20877
Party NameOncoArrestin, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGaithersburg, MD 20877
Party NameOncoArrestin, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGaithersburg, MD 20877

Trademark Events

Event DateEvent Description
Friday, September 28, 2012CANCELLED SEC. 8 (6-YR)
Thursday, May 7, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 21, 2006REGISTERED-PRINCIPAL REGISTER
Monday, January 9, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, January 5, 2006ASSIGNED TO LIE
Tuesday, December 13, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 13, 2005ASSIGNED TO EXAMINER
Tuesday, December 13, 2005STATEMENT OF USE PROCESSING COMPLETE
Sunday, November 20, 2005USE AMENDMENT FILED
Monday, November 21, 2005TEAS STATEMENT OF USE RECEIVED
Wednesday, May 4, 2005EXTENSION 4 GRANTED
Wednesday, May 4, 2005EXTENSION 4 FILED
Wednesday, May 4, 2005TEAS EXTENSION RECEIVED
Wednesday, November 24, 2004EXTENSION 3 GRANTED
Wednesday, November 17, 2004EXTENSION 3 FILED
Wednesday, November 17, 2004TEAS EXTENSION RECEIVED
Wednesday, June 2, 2004EXTENSION 2 GRANTED
Wednesday, May 19, 2004EXTENSION 2 FILED
Thursday, May 27, 2004CASE FILE IN TICRS
Wednesday, May 19, 2004TEAS EXTENSION RECEIVED
Wednesday, November 5, 2003EXTENSION 1 GRANTED
Tuesday, October 28, 2003EXTENSION 1 FILED
Tuesday, October 28, 2003TEAS EXTENSION RECEIVED
Tuesday, May 20, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 25, 2003PUBLISHED FOR OPPOSITION
Wednesday, February 5, 2003NOTICE OF PUBLICATION
Thursday, December 12, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2002NON-FINAL ACTION MAILED
Monday, December 2, 2002ASSIGNED TO EXAMINER

Related Keywords

oncoarrestin development molecular consultation field technical analysis namely product research